MedPath

CAMZYOS 2,5 MG CAPSULAS DURAS

CAMZYOS 2,5 MG CAPSULAS DURAS

Commercialized
Register Number

1231716002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 3, 2023

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1231716002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

MAVACAMTENActive
Quantity: 2,5 mg
Name: MAVACAMTEN

ATC CLASSIFICATION (3)

C01E
C01EB
C01EB24

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.